Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2010
12/22/2010CN1886380B Benzoimidazole compounds
12/22/2010CN1812973B Indazole compounds useful as protein kinase inhibitors
12/22/2010CN101925596A Beta-amino acid derivatives for treatment of diabetes
12/22/2010CN101925586A Novel heterocyclic compounds
12/22/2010CN101925584A Pyrimidine derivatives for treatment of asthma, COPD, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, HIV, HPV, bacterial infections and dermatosis
12/22/2010CN101921267A Beta -lactamyl vasopressin Vla antagonists
12/22/2010CN101921265A Biphenylacylamine tetrazole compounds, synthetic method and application
12/22/2010CN101921264A Candesartan organic amine salt and preparation method and application thereof
12/22/2010CN101921263A 2-metridazloe derivative as well as application and preparation method thereof
12/22/2010CN101921236A 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
12/22/2010CN101337937B N-benz-3-substituted amino pyrazoles compounds with insecticidal activity
12/22/2010CN101056864B Method for preparing pyrimidine compound
12/21/2010US7855298 (1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-3-azabicyclo[3.1.0]hexane; or(1S,5R)-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; schizophrenia
12/21/2010US7855291 Process for the preparation of substituted phenylalanines
12/21/2010US7855290 Pyridine derivatives and pyrimidine derivatives (3)
12/21/2010US7855215 such as 6-(6-Amino-pyrimidin-4-yloxy)-3,4-dihydro-2H-quinoline-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide, used for the treatment of leukemia
12/21/2010US7855214 Autoimmune, inflammatory, proliferative, or hyperproliferative disease or an immunologically-mediated disease; inhibitors of the Tec family of non-receptor tyrosine kinases; compounds are quinazolino[3,2-a]quinazolin-12-ones
12/21/2010US7855213 e.g. 3-(3'-Methoxy-biphenyl-3-yl)-3-(4-methoxy-phenyl)-3H-isoindol-1-ylamine trifluoroacetate; beta -secretase, pepsin-like aspartic proteinase inhibitor; neurodegenerative diseases, cognitive impairment, Alzheimer's, Parkinson's Diseases, Down syndrome, and dementia
12/21/2010US7855212 Pyridinyl acetonitriles
12/21/2010US7855210 Hydroxyiminopiperazine compounds, used as vanilloid receptor antagonists; analgesics
12/21/2010US7855209 2-aminothiophene derivatives; {2-Amino-4-[(4-phenylpiperazin-1-yl)methyl]thiophen-3-yl}(4-chlorophenyl)methanone; analgesic for chronic neuropathic pain, cardiac disarrhythmias, angina; neurological disease or injury, sleep disorder, epilepsy, antidepressants
12/21/2010US7855207 such as 6-[(1R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-piperidin-1-ylpropyl]-3-ethyl-1H-quinolin-2-one, used for treating cancer and/or preventing cellular, tissue and/or organ damage resulting from cell damage or death due to, for example, necrosis or apoptosis
12/21/2010US7855205 Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
12/21/2010US7855203 Indazolyl-substituted pyrroline compounds as kinase inhibitors
12/21/2010US7855199 antitumor agents such as 2-(2-difluoromethyl-4-methoxybenzimidazol-1 -yl)-4-(cis-2,6-dimethylmorpholino)-6-morpholinopyrimidine, used for inhibiting the growth of a human colon cancer cell, a human lung cancer cell, a human breast cancer cell or a human prostate cancer cell
12/21/2010US7855194 Pyrimidine, quinazoline, pteridine and triazine derivatives
12/21/2010CA2569654C Benzimidazolone carboxylic acid derivatives
12/21/2010CA2532067C N-methyle-substituted benzamidazoles
12/21/2010CA2457575C 3-phenoxy-4-pyridazinol derivatives and herbicidal composition containing the same
12/21/2010CA2423351C Novel arylalkane-sulfonamides
12/16/2010WO2010144646A2 Anti-viral compounds
12/16/2010WO2010144477A2 Sulfonylurea modulators of endothelin receptor
12/16/2010WO2010144468A1 2- ( lh-pyrazol-4 -ylamino ) -pyrimidine as kinase inhibitors
12/16/2010WO2010143803A2 New nicotinamide derivatives with anti-androgen effects, processes of preparing, and antiandrogens comprising the same
12/16/2010WO2010143762A1 Compound for inhibiting activity of ribonuclease, and container for storing nucleic acid containing the same
12/16/2010WO2010143664A1 Tetracyclic compound
12/16/2010WO2010142994A1 2, 3-dihydro-1h-indene compounds and their use to treat cancer
12/16/2010WO2010142934A1 Indole derivatives as ligands of crth2 receptors
12/16/2010WO2010142801A1 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
12/16/2010WO2010142656A1 Heterocyclic antiviral compounds
12/16/2010WO2010142426A1 Hedgehog pathway antagonists and therapeutic applications thereof
12/16/2010WO2010142183A1 Pharmaceutical composition for treatment of type 2 diabetes in mammals including human beings
12/16/2010WO2010142182A1 Pharmaceutical composition for treatment of type 2 diabetes in mammals including human beings
12/16/2010WO2010083241A3 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders
12/16/2010WO2010052569A3 Triazine, pyrimidine and pyridine analogs and their use as therapeutic agents and diagnostic probes
12/16/2010WO2007051081A8 Methods and compounds for preparing cc-1065 analogs
12/16/2010US20100317854 Novel aminodicarboxylic acid derivatives having pharmaceutical properties
12/16/2010US20100317851 Luminophores
12/16/2010US20100317842 Development of Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry
12/16/2010US20100317712 Estrogen Agonists/Antagonists For Preventing Breast Cancer
12/16/2010US20100317674 Metabotropic Glutamate-Receptor-Potentiating Isoindolones
12/16/2010US20100317665 Anti-Inflammatory And Protein Kinase Inhibitor Compositions And Related Methods For Downregulation Of Detrimental Cellular Responses And Inhibition Of Cell Death
12/16/2010US20100317659 Jak kinase modulating compounds and methods of use thereof
12/16/2010US20100317652 Compounds Useful In Therapy
12/16/2010US20100317647 Novel cyclopentane derivatives
12/16/2010US20100317644 Substituted Sulfonamide Compounds
12/16/2010US20100317568 Anti-Viral Compounds
12/16/2010US20100317100 Compositions and methods for establishing and maintaining stem cells in an undifferentiated state
12/16/2010US20100316607 Hepatitis c virus inhibitors
12/16/2010US20100316601 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof
12/16/2010CA2847910A1 Anti-viral compounds
12/16/2010CA2765263A1 Compound for inhibiting activity of ribonuclease, and container for storing nucleic acid containing the same
12/16/2010CA2765181A1 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
12/16/2010CA2765150A1 2, 3-dihydro-1h-indene compounds and their use to treat cancer
12/16/2010CA2765114A1 Hedgehog pathway antagonists and therapeutic applications thereof
12/16/2010CA2765050A1 Ureidophenyl substituted triazine derivatives and their therapeutical applications
12/16/2010CA2765044A1 Benzyl substituted triazine derivatives and their therapeutical applications
12/16/2010CA2765030A1 Triazine derivatives and their therapeutical applications
12/16/2010CA2764983A1 2- ( lh-pyrazol-4 -ylamino ) -pyrimidine as kinase inhibitors
12/16/2010CA2764980A1 Styryl-triazine derivatives and their therapeutical applications
12/16/2010CA2764823A1 Triazine derivatives and their therapeutical applications
12/16/2010CA2764818A1 Triazine derivatives and their therapeutical applications
12/16/2010CA2764653A1 Tetracyclic compounds
12/16/2010CA2764141A1 Heterocyclic antiviral compounds
12/16/2010CA2764027A1 Compounds useful for treating premature aging and in particular progeria
12/16/2010CA2764024A1 Compounds useful for treating cancer
12/16/2010CA2737601A1 Anti-viral compounds
12/15/2010EP2262030A2 Organic light emitting device
12/15/2010EP2261218A2 Process for preparing phenyl-, pyridinyl- or pyrimidinyl-substituted imidazoles
12/15/2010EP2261206A1 Indolinone compound
12/15/2010EP2260036A2 Polycyclic organic compounds, retardation layer and compensation panel on their base
12/15/2010EP2260031A1 Compounds that are erk inhibitors
12/15/2010EP2260030A2 2-alkynyl-6-pyridin-2-yl-pyridazinones, 2-alkynyl-6-pyridin-2-yl-dihydropyridazinones, 2-alkynyl-6-pyrimidin-2-yl-pyridazinones and 2-alkynyl-6-pyrimidin-2-yl-dihydropyridazinones and their use as fungicides
12/15/2010EP2260022A1 Substituted cyclohexyldiamines
12/15/2010EP2260020A1 Hydroxamate-based inhibitors of deacetylases b
12/15/2010EP2000465B1 Triazolone derivative
12/15/2010EP1866292B1 Tricyclic 1,2,4-triazine oxides and compositions therefrom for therapeutic use in cancer treatments
12/15/2010EP1740578B1 4- 2- (cycloalkylamino) pyrimidin-4-yl ] - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
12/15/2010EP1501822B1 Phthalazinone derivatives
12/15/2010EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof
12/15/2010CN1993324B 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders
12/15/2010CN1984660B 4-arylamino-quinazolines as activators of aspartic acid specificity cysteine protease and inducers of apoptosis
12/15/2010CN101918391A Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
12/15/2010CN101918371A Amide derivatives as sirtuin modulators
12/15/2010CN101918369A N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (HCV) inhibitors
12/15/2010CN101914092A Azabicyclo alkane derivative and preparation method and application thereof in medicaments
12/15/2010CN101914091A Method for preparing voriconazole intermediate
12/15/2010CN101914065A Pyrimidinylacetic acid derivatives useful for the treatment of diseases mediated by crth2
12/14/2010US7851634 enzyme inhibitors such as N-(2-Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2-isopropyl-7-[3-(3-methoxypropyl)-1H-indol-5-ylmethyl]-8-methylnonanamide, used as hypotensive agents
12/14/2010US7851626 4,4,5,5, tetrasubstituted imidazolines
1 ... 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 ... 626